Black Titan Corp (NASDAQ:BTTC) Shares Shorted: Short Interest Down 51.6% in September

Posted by Francis Steltz on Sep 30th, 2026

Black Titan Corp (NASDAQ:BTTC – Get Free Report) saw a large decrease in short interest during the month of September. As of September 15th, there was short interest totaling 10,495 shares, a decrease of 51.6% from the August 31st total of 21,671 shares. Based on an average daily volume of 108,286 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.2% of the company’s shares are short sold.

Black Titan Trading Up 12.3%

Shares of BTTC traded up $0.06 during trading hours on Wednesday, hitting $0.52. 65,320,907 shares of the stock were exchanged, compared to its average volume of 3,827,918. Black Titan has a fifty-two week low of $0.34 and a fifty-two week high of $39.00. The business has a 50-day moving average of $0.58 and a 200-day moving average of $0.93. The firm has a market capitalization of $5.60 million, a P/E ratio of -0.18 and a beta of 1.17. The company has a debt-to-equity ratio of 0.06, a current ratio of 4.62 and a quick ratio of 4.62.

Black Titan Company Profile

(Get Free Report)

Titan Pharmaceuticals, Inc is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.

Black Titan Corp (NASDAQ:BTTC) Shares Shorted: Short Interest Down 51.6% in September

Black Titan Trading Up 12.3%

Black Titan Company Profile

Further Reading

You might be interested in: